Argenx
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
81 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
June 27, 2018 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 6, 2019 | Marshall Wace LLP | 0.91% | March 11, 2019 |
| March 4, 2019 | Marshall Wace LLP | 0.82% | March 6, 2019 |
| February 27, 2019 | Marshall Wace LLP | 0.71% | March 4, 2019 |
| February 19, 2019 | Marshall Wace LLP | 0.62% | February 27, 2019 |
| February 4, 2019 | Marshall Wace LLP | 0.52% | February 19, 2019 |
| January 21, 2019 | Marshall Wace LLP | 0.59% | January 24, 2019 |
| January 15, 2019 | Marshall Wace LLP | 0.68% | January 21, 2019 |
| January 14, 2019 | Marshall Wace LLP | 0.76% | January 15, 2019 |
| January 14, 2019 | Citadel Advisors LLC | 0.50% | January 22, 2019 |
| January 11, 2019 | Healthcor Management, L.P. | 0.52% | January 15, 2019 |
| January 9, 2019 | Marshall Wace LLP | 0.89% | January 14, 2019 |
| January 2, 2019 | Citadel Advisors LLC | 0.51% | January 10, 2019 |
| December 28, 2018 | Marshall Wace LLP | 0.91% | January 9, 2019 |
| December 21, 2018 | Marshall Wace LLP | 0.84% | December 28, 2018 |
| December 19, 2018 | Marshall Wace LLP | 0.70% | December 21, 2018 |
| December 12, 2018 | Marshall Wace LLP | 0.69% | December 19, 2018 |
| December 10, 2018 | Marshall Wace LLP | 0.70% | December 12, 2018 |
| December 6, 2018 | Marshall Wace LLP | 0.67% | December 10, 2018 |
| December 4, 2018 | Marshall Wace LLP | 0.58% | December 6, 2018 |
| December 3, 2018 | Marshall Wace LLP | 0.60% | December 4, 2018 |
| November 27, 2018 | Marshall Wace LLP | 0.87% | December 3, 2018 |
| November 21, 2018 | Marshall Wace LLP | 0.94% | November 27, 2018 |
| November 20, 2018 | Marshall Wace LLP | 1.09% | November 21, 2018 |
| November 19, 2018 | Marshall Wace LLP | 1.11% | November 20, 2018 |
| November 14, 2018 | Marshall Wace LLP | 1.03% | November 19, 2018 |
| November 12, 2018 | Marshall Wace LLP | 0.91% | November 14, 2018 |
| November 6, 2018 | Marshall Wace LLP | 0.80% | November 12, 2018 |
| November 1, 2018 | Marshall Wace LLP | 0.71% | November 6, 2018 |
| October 25, 2018 | Marshall Wace LLP | 0.63% | November 1, 2018 |
| October 19, 2018 | Marshall Wace LLP | 0.50% | October 25, 2018 |
| June 27, 2018 | Marshall Wace LLP | 0.51% | July 2, 2018 |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Argenx, source FSMA, data as at May 10, 2021, https://www.quivad.com/action/argenx?page=2